Clinical trial
A Phase II Trial of Perillyl Alcohol in Patients With Resectable Pancreatic Cancer
NCT00003769 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Perillyl Alcohol in Patients With Resectable Pancreatic Cancer
- Lead sponsor
- Indiana University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 1999
- Completion date
- July 31, 2001
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancer